Study to Evaluate How Patients Regard the Benefits and Risks of Low-dose Aspirin for the Prevention of Heart and Blood Vessels Disease and for the Prevention of Cancer of the Colon and Rectum
Clinical trial NCT03603366 · COMPLETED
Trial details
- NCT number
- NCT03603366
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-08-14
- Primary completion
- 2019-10-14
- Enrollment
- 1028
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.